Ping‐Yi Wu
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 1
- Co-authors
- Mi‐Hua Tao (7 shared papers)Koichi Tsuneyama (2 shared papers)Chia‐Ming Chang (2 shared papers)I‐Jung Lee (1 shared paper)Yin Maggie Chen (1 shared paper)Chun-Chi Chen (2 shared papers)Steve R. Roffler (1 shared paper)Yi-Jou Huang (1 shared paper)
- Journals
- Human Gene Therapy (2 papers)PLoS Pathogens (2 papers)Scientific Reports (2 papers)Emerging Microbes & Infections (1 paper)Autoimmunity Reviews (1 paper)
- Partner nations
- TaiwanUnited StatesJapan
In The Last Decade
Ping‐Yi Wu
13 papers receiving 337 citations
Peers
Comparison fields: 5 of 37
- Infectious Diseases 121
- Immunology 76
- Hepatology 29
- Oncology 49
- Genetics 42
Countries citing papers authored by Ping‐Yi Wu
This map shows the geographic impact of Ping‐Yi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping‐Yi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping‐Yi Wu more than expected).
Fields of papers citing papers by Ping‐Yi Wu
This network shows the impact of papers produced by Ping‐Yi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping‐Yi Wu. The network helps show where Ping‐Yi Wu may publish in the future.
Co-authors
The 22 scholars most cited alongside Ping‐Yi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 56 | |
| 2 | 2018 | 54 | |
| 3 | 2010 | 36 | |
| 4 | 2021 | 36 | |
| 5 | 2010 | 30 | |
| 6 | 2003 | 23 | |
| 7 | 2021 | 22 | |
| 8 | 2009 | 20 | |
| 9 | 2015 | 19 | |
| 10 | 2013 | 18 | |
| 11 | 2021 | 12 | |
| 12 | 2023 | 11 | |
| 13 | 2022 | 7 |
About Ping‐Yi Wu
Ping‐Yi Wu is a scholar working on Infectious Diseases, Immunology, Hepatology, Genetics and Oncology, having authored 13 papers that have together received 344 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Virus-based gene therapy research (3 papers), Immunotherapy and Immune Responses (3 papers), RNA Interference and Gene Delivery (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Immune Cell Function and Interaction (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Infectious Diseases (121 citations), Immunology (76 citations), Hepatology (29 citations), Oncology (49 citations) and Genetics (42 citations). Ping‐Yi Wu has collaborated with scholars based in Taiwan, United States and Japan. Frequent co-authors include Mi‐Hua Tao, Koichi Tsuneyama, Chia‐Ming Chang, I‐Jung Lee, Yin Maggie Chen, Chun-Chi Chen, Steve R. Roffler, Yi-Jou Huang, Amy Dhirapong and Cheng‐Pu Sun. Their work appears in journals such as Human Gene Therapy, PLoS Pathogens, Scientific Reports, Emerging Microbes & Infections and Autoimmunity Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.